Clinical Trials Browser

Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT06220032 2026-01-05

HO170DLBCL

Phase 3 Recruiting

324 enrolled

LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Clinical Trials

CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)

Pembrolizumab in Neoplasms or Lymphomas

Modified R-MINE Regimen vs. R-GemOx Regimens on the Treatment of Late Relapsed DLBCL

Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

Glofitamab Combined With CAR-T Therapy in R/R DLBCL

Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy

HO170DLBCL